About us | Universitätsmedizin Göttingen

JavaScript scheint in Ihrem Browser deaktiviert zu sein. Sie müssen JavaScript in Ihrem Browser aktivieren um alle Funktionen der Seite nutzen zu können.

CCC-N > About us

Our Projects

SP1: Understanding and exploiting molecular and cellular reprogramming in response to EZH2 inhibition in PDAC
SP2: Characterizing subtype-specific adaptation to epigenetic therapy in PDAC
SP3: Characterization of the epigenomic landscape that contributes to adaptation to molecular therapies in HCC
SP4: Exploring ER stress-induced metabolic adaptation in the treatment of PDAC
SP5: Understanding and exploiting adaptation to asparagine deprivation in GI cancer
SP6: Investigating adaptation of rectal cancer to neoadjuvant therapy
SP7: Understanding and exploiting tumor cell specific adaptations to targeted therapies in BTC
SP8: Dissecting the influence of an intact immune system on the DTP state under targeted therapies in biliary tract cancer
SP9: Dissecting adaptation of the tumor microenvironment upon targeting of mutp53 subtypes in colorectal and pancreatic cancer
SP10: Dissecting adaptation of the microbiome and the immune environment in BTC and PDAC upon systemic therapies
SP11: Elucidating and targeting of vessel co-option as adaptation under anti-angiogenic therapy for colorectal cancer
SP12: Identification of predictive biomarkers of systemic immune cell adaptation in patients undergoing locoregional or surgical HCC therapy